KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Revenue (2016 - 2025)

Historic Revenue for Arbutus Biopharma (ABUS) over the last 17 years, with Q3 2025 value amounting to $529000.0.

  • Arbutus Biopharma's Revenue fell 6049.29% to $529000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $14.6 million, marking a year-over-year increase of 11664.19%. This contributed to the annual value of $6.2 million for FY2024, which is 6598.31% down from last year.
  • Per Arbutus Biopharma's latest filing, its Revenue stood at $529000.0 for Q3 2025, which was down 6049.29% from $10.7 million recorded in Q2 2025.
  • Arbutus Biopharma's Revenue's 5-year high stood at $14.2 million during Q2 2022, with a 5-year trough of $529000.0 in Q3 2025.
  • Moreover, its 5-year median value for Revenue was $3.2 million (2021), whereas its average is $4.6 million.
  • As far as peak fluctuations go, Arbutus Biopharma's Revenue plummeted by 7708.99% in 2024, and later skyrocketed by 52219.0% in 2025.
  • Arbutus Biopharma's Revenue (Quarter) stood at $3.2 million in 2021, then surged by 94.79% to $6.2 million in 2022, then crashed by 65.65% to $2.1 million in 2023, then dropped by 26.62% to $1.6 million in 2024, then tumbled by 66.39% to $529000.0 in 2025.
  • Its last three reported values are $529000.0 in Q3 2025, $10.7 million for Q2 2025, and $1.8 million during Q1 2025.